Arriola, E., Wheater, M., Galea, I., Cross, N., Maishman, T., Hamid, D., . . . Ottensmeier, C. (2016). Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC. J Thorac Oncol.
Citação norma ChicagoArriola, Edurne, et al. "Outcome and Biomarker Analysis From a Multicenter Phase 2 Study of Ipilimumab in Combination With Carboplatin and Etoposide As First-Line Therapy for Extensive-Stage SCLC." J Thorac Oncol 2016.
ציטוט MLAArriola, Edurne, et al. "Outcome and Biomarker Analysis From a Multicenter Phase 2 Study of Ipilimumab in Combination With Carboplatin and Etoposide As First-Line Therapy for Extensive-Stage SCLC." J Thorac Oncol 2016.